Mannkind shares halted ahead of AdComm meeting


Trading in Mannkind's (MNKD) shares has been halted ahead of an FDA advisory committee meeting to discuss whether to recommend approving the company's Afrezza inhalable insulin.

From other sites
Comments (2)
  • Professorredbag
    , contributor
    Comments (43) | Send Message
     
    Did they remain halted after hours as well or begin trading again? There are conflicting reports here on SA.
    2 Apr 2014, 02:45 AM Reply Like
  • shalomshachne
    , contributor
    Comments (5) | Send Message
     
    Looks like Adcom approved it...
    2 Apr 2014, 10:01 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs